Cancer Subtypes Significantly Vary Myocardial Infarction Risk

A nationwide Danish study of 660,531 patients has identified significant variations in the risk of myocardial infarction (MI) across 13 different cancer types.

Published in the International Journal of Cardiology, the research tracked adult patients diagnosed with cancer between 2000 and 2023 to determine how specific malignancies influence cardiovascular health within the first year of diagnosis.

Researchers excluded patients with a prior history of heart attacks or coronary revascularization to isolate the potential impact of the cancer diagnosis itself. The study used patients with low-risk skin tumors as a reference group to establish relative risk across the remaining cancer categories.

Multiple myeloma emerged with the highest relative risk for a heart attack, calculated at 1.80 times that of the reference group. Several other cancer types also showed elevated susceptibility, suggesting that cardiovascular monitoring may need to be tailored based on the specific cancer diagnosis.

Cancer Subtype Relative MI Risk
Multiple Myeloma 1.80
Bladder Cancer 1.52
Kidney Cancer 1.51
Leukemia 1.45
Gastrointestinal Cancer 1.37

Despite these variations in relative risk, the standardized one-year absolute MI risk remained below 1% for all cancer subtypes studied. Breast cancer patients showed the lowest absolute risk at 0.31%, while multiple myeloma patients reached 0.91%.

The study authors highlighted that these findings must be interpreted alongside the competing risk of mortality. In some groups, such as patients with hepatobiliary and pancreatic cancer, all-cause mortality reached 71.9% within the first year. Consequently, a low observed incidence of heart attacks in high-mortality cancer groups may not reflect a true lack of cardiovascular susceptibility, but rather the overwhelming impact of the cancer itself.

The researchers categorized these findings as hypothesis-generating, noting that the observational study did not establish a direct causal link between cancer subtypes and heart attacks. The data set lacked consistent information regarding specific treatment regimens, timing of interventions, and certain lifestyle-related cardiovascular risk factors.

The study authors stressed that clinicians must interpret cardiovascular outcomes in light of each patient's overall prognosis. Future research is expected to clarify how the interaction between cancer treatment, tumor biology, and underlying cardiovascular risk drives these early clinical outcomes.

Why were skin tumor patients used as a reference group?
The researchers selected patients with low-risk skin tumors as a cancer-active control population rather than comparing them to a completely cancer-free group. This approach helped the team account for the baseline stress of a cancer diagnosis.

Does this study prove cancer causes heart attacks?
No. The authors characterize the results as hypothesis-generating and emphasize that the observational nature of the study does not establish that specific cancer subtypes directly cause the observed differences in heart attack risk.

How does cancer mortality affect these heart attack findings?
High mortality rates in certain cancer groups can mask cardiovascular risk. The authors note that when a large percentage of patients die from their cancer within a year, the statistical window to observe a heart attack is significantly shortened.

The International Journal of Cardiology, which began publication in 1981, is devoted to the field of cardiology in its broadest sense. The peer-reviewed medical journal serves both researchers and practicing clinicians by publishing a wide range of basic research and clinical papers.

The findings are detailed in the study, "Myocardial infarction risk across cancer subtypes – a nationwide registry-based follow-up study," published in the International Journal of Cardiology in January 2027.